Charles P. Cox

Title: Director, Commercialization Practice

Category: Managing Professional

Education: B.A., Zoology; M.B.A.; Ph.D, Medical Microbiology & Immunology

Dr. Cox is a pharmaceutical industry consultant experienced in project management, technology transfer, licensing, due diligence and commercialization of biopharmaceutical products. Dr. Cox was previously Senior Vice President of Corporate Development for Atrix Laboratories, Inc . He was responsible for developing strategic plans, identifying potential new products utilizing proprietary drug delivery technologies, and then securing partners for developing these products. He was also responsible for licensing the technologies to major pharmaceutical companies for use with their own proprietary molecules. While at Atrix, Dr. Cox negotiated the domestic and international license, development and marketing agreements for Atrix’s proprietary Eligard™ sustained release products for treating prostate cancer. He was the co-leader of the due diligence team that acquired another drug delivery company and merged it into Atrix.

Dr. Cox received his B.A from the University of Tulsa, and his M.S. and Ph.D. from the University of Oklahoma Health Sciences Center. He completed Postdoctoral Research training at National Jewish Hospital and Research Center before returning to serve as an Assistant Professor of Medicine in the Pulmonary Disease Section at the University of Oklahoma School of Medicine and the Veterans Administration Research Service. Dr. Cox started his industry career as a laboratory director in the R&D Division of G.D. Searle & Co. in Chicago, where he also served as Director of R&D Project Management. He subsequently completed an M.B.A. at the Kellogg Graduate School of Management at Northwestern University, focusing on marketing and international business. Dr. Cox is a member of the Licensing Executive Society.